Clavulanate Potassium/Ticarcillin Disodium

在植物组织培养中，农杆菌是常用的一种革兰氏阴性菌，在自然条件下，它能感染大多数双子叶植物和裸子植物受损部位。受损部位的细胞分泌大量酚类化合物，吸引农杆菌到这些细胞，诱导冠瘤或多毛根的形成。农杆菌污染导致的实验失败也是困扰许多研究者的难题。特美汀做为一种高效复合抗生素，可以有效抑制农杆菌。 作用机理 特美汀Timentin组分为替卡西林钠及克拉维酸钾，按有效酸计，替卡西林钠与克拉维酸钾的配比为15:l，替卡西林是青霉素类杀菌试剂，而克拉维酸则是一种不可逆性高效β-内酰胺酶抑制剂。多种革兰氏阳性菌（G+）和阴性菌（G-）都能产生β-内酰胺酶，这类酶能在青霉素作用于病原体之前将其破坏。克拉维酸通过阻断β-内酰胺酶破坏细菌的防御屏障，恢复替卡西林敏感性。克拉维酸钾单独抗菌作用甚微，但与替卡西林配置后使本品成为具有广谱杀菌作用的抗生素，适用于对广泛的细菌感染性疾病的经验治疗。本试剂在科研中常用与抑制农杆菌生长，特别在胚性愈伤组织再生系统中，能达到很好的抑菌和再生效果。 优势 农杆菌抑制效率更高：特美汀抑制常见植物感染农杆菌：根癌农杆菌（Agrobacterium tumefaciens）和发根农杆菌（Agrobacterium rhizogenes）的效率更高； 适用于难以转化材料：针对难转化组织培养材料，以及难以用其他抗生素抑制的植物 对植物材料影响小：对愈伤组织形成和植物再生的影响小，特别适合当其他抗生素影响植物再生潜能的条件下。 相关产品 百瑞极Biorigin可提供干粉状态及无菌溶液的特美汀，现货充足，溶液浓度可定制，满足您的多种需求。 北京百瑞极生物科技有限公司（Biorigin(Beijing)Inc.）是一家研发生产生命科学试剂的高新技术企业。公司聘请国内外专家团队合作建立了多种技术平台，产品涉及细胞生物学、分子生物学、免疫学、植物学、微生物学、生物化学等领域，以细胞染色标记技术为代表的细胞检测试剂，及核酸纯化定量和PCR技术为代表的分子生物学试剂是公司的优势特色。 百瑞极主营业务是高端生命科学实验试剂，包括细胞生物学、分子生物学、生理生化等方面的试剂和试剂盒，以及普通生化试剂和耗材等，产品广泛应用于生物科研、医学科研和工业生产。 百瑞极始终坚持“掌握源头技术，服务生命科学，做高端试剂国产化领先者”的发展理念，规范企业运营，严格质量管理，打造覆盖研发和生产的完备产业链布局，公司愿景是发展成为国内生命科学领域强竞争力的高新技术企业。 北京拜尔迪生物是百瑞极Biorigin授权代理商，更多活动及产品，欢迎咨询订购！ 北京拜尔迪 热线：010-62960866 网址：www.biodee.net 北京拜尔迪生物(BioDee)，成立于2003年，国家级高新技术企业，多个进口品牌和优秀国产品牌的一级代理商，专注于生命科学领域，为客户提供试剂、耗材、仪器等产品，涵盖了细胞生物学、微生物学、植物学、分子生物学、生物化学、免疫学等领域。

The first steps in the integration of Ireland’s sole GMP-approved manufacturers of Beta-Lactam antibiotics, which merged in December 2025 through a horizontal acquisition, have met corporate objectives for synergy as the companies strengthen their market positions, enhance capabilities and leverage efficiencies. Post-merger integration in the pharmaceutical sector is a critical process that focuses on aligning business cultures, technologies, systems and operations. However, it presents unique complexities in merging clinical, regulatory and administrative systems. These are the challenges that Gaelic Laboratories, and its newly acquired sister company Athlone Laboratories, have been addressing since they completed their deal in 2025. Marking the completion of the first phase of integration and providing an effective modus for a combined service offering, a new joint website describes the two companies’ complementary services. Both Gaelic Labs and Athlone are well established, GMP-approved manufacturers with strong reputations in Beta-Lactam antibiotics. Together, they manufacture a large range of oral products that help address demands for critical medicines in Ireland, as well as in the UK and EU, Middle East and North Africa (MENA), Canada and Australia. “The new website effectively lets our customers and partners see the full range of our combined offering to the market,” says Brian Morrissey, General Manager. “That includes a complete list of both companies’ manufacturing capabilities for different antibiotics, finished product formulations and dosages, packaging services, contract analytical services, and regulatory expertise in different parts of the world.” Operational efficiencies are already evident as the two companies have aligned and consolidated administrative systems such as IT and compliance, as well as supply chains. An extensive internal communications programme, including the launch of a new newsletter called “ The Capsule ” has greatly helped with improving internal communications at Athlone, helping to fully align business cultures and providing the necessary reassurance of continuity despite the leadership change. “Both Gaelic and Athlone are key players in the supply chain for Beta-Lactam antibiotics,” continues Brian. “As we mark the end of the first stage of our integration process, I am pleased to see that the synergies we predicted are already coming to fruition, with a seamless transition for our customers and partners, and I firmly believe that we are going to enhance the future of Beta-Lactams supply in Ireland and Europe.” The integration now means that the companies’ leadership can make the most effective use of the combined assets of both companies, across facilities, capabilities and skilled personnel. Phase 2 of the integration process is already underway, with a view to further optimizing manufacturing processes for greater efficiencies across both sites . For more information about Gaelic Laboratories and Athlone Laboratories, visit their new website at . Editor’s Note For more information, please contact Tristan Jervis at Impact Shine Communications on +44 (0) 771 363 8396 or e-mail: t.jervis@impactshinecommunications.com . About Gaelic Laboratories Gaelic Laboratories is a world-class manufacturer of Beta-Lactam (penicillin) products in tablet, capsule and powder for suspension form. Established in Ireland in 2022, and with newly upgraded facilities, we manufacture our own Beta-Lactam products (sold under the Gaelic Laboratories brand), as well as offering contract manufacturing and packaging services for markets across the EU, UK, the Middle East and North Africa. Our site in Ireland is licenced by the HPRA. About Athlone Laboratories Athlone Laboratories a leading developer and manufacturer of a broad range of oral dose beta-lactam products. Established in 1974, the company is an accredited supplier to local and many blue-chip customer partners across Europe, Asia-Pacific, Canada, Iraq and Brazil Our site in Ireland is licenced by the HPRA. Athlone Laboratories was acquired by Gaelic Laboratories in December 2025.